methylation analysis
UPDATE: A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
The company plans to launch several multiomics products, including an epigenetics analysis assay, as soon as next year.
Lucid Diagnostics' Esophageal Precancer Test Sales Spike in Q2
The firm's revenues, all from the EsoGuard DNA screening test, increased to $976,000 in Q2 compared to $159,000 in the same quarter last year.
Multi-Cancer Early Detection Paper Offers Open-Source Scaffold For Potential Clinical Translation
Premium
Investigators developed a methylation-based framework for detecting and classifying cancers, which they hope can be adapted for screening and other applications.
Biomodal Sues New England Biolabs for Patent Infringement
The company alleges that NEB's NEBNext products infringe on patents covering Biomodal's Duet Multiomics Solution evoC and +modC products.
Mar 21, 2024
Feb 5, 2024
Sep 25, 2023
Oct 28, 2022
Aug 11, 2022